Amphion Innovations plc

Statement Regarding Price Movement

London and New York, 7 February 2019 - Amphion Innovations plc (AIM:AMP), the developer of medical, life science, and technology businesses, notes the recent movement in its share price and, notwithstanding the recent share price increase of its Partner Companies Motif Bio plc ("Motif"), in which the Company has a holding of approximately 8.5 per cent. and Polarean Imaging Plc in which the Company has a holding of approximately 18.2 per cent., confirms that it is not aware of any specific reason for this movement.

The Company remains cash constrained and as previously announced continues to consider both its short term and medium-term funding options and work with the Company's debt providers, including the Convertible Promissory Note ("CPN") holders with whom the Company has been able to reach accommodations in the past. The Company is proposing to extend the term of the debt to 31 December 2019 following expiration of the CPN on 31 December 2018. A further announcement will be made in this regard in due course.

 

---

For further information please contact

Amphion Innovations
Charlie Morgan
+1 212 210 6224

Panmure Gordon Limited (Nominated Adviser and Corporate Broker)
Freddy Crossley / Emma Earl (Corporate Finance)
Charlie Leigh-Pemberton (Corporate Broking)
+44 (0)20 7886 2500

SP Angel Corporate Finance LLP (Joint Corporate Broker)
David Hignell (Corporate Finance)
Rob Rees (Corporate Broking)
+44 (0)20 3470 0470

Walbrook PR
Anna Dunphy / Paul McManus
+44 (0)20 7933 8780

About Amphion Innovations plc
Amphion Innovations is a developer of medical, life science and technology businesses.

We use our extensive experience in company building to invest and build shareholder value in high growth companies in the US and UK. Amphion has significant shareholding in a small number of Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies.